Colgate-Palmolive Director Brian Newman Acquires Shares via Deferred Fee Plan
COLGATE PALMOLIVE CO
Subscribe to track CL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Colgate-Palmolive Co ($CL) Insider: Newman Brian (Director) Type: Acquisition (Award/Deferred Retainer) Shares: 214 @ $87.42 (~$18.7K) Shares Owned After: 8,058 direct (+ 36 indirect) Significance: Low (Routine Director Compensation)
Comprehensive Analysis
Overview
On October 1, 2026, Colgate-Palmolive Co ($CL) Director Brian Newman acquired 214 shares of Common Stock at an implied price of $87.42 per share, totaling approximately $18,707.88.
Transaction Details
- Nature of Transaction: The acquisition was coded as 'A' (Grant/Award). Per footnote 1, this represents a portion of Newman's annual cash retainer deferred into a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
- Direct vs. Indirect Holdings: Following the transaction, Newman directly holds 8,058 shares of Common Stock. Additionally, Newman indirectly holds 36 shares through a Family Trust.
Market Significance
- Trading Significance: Low. This transaction is part of standard, scheduled board compensation deferral rather than an open-market, discretionary purchase. It indicates alignment with shareholders but does not represent an active directional trading signal.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.